Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Equity (2022 - 2025)

Historic Return on Equity for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to 1.72%.

  • TriSalus Life Sciences' Return on Equity fell 7800.0% to 1.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.72%, marking a year-over-year decrease of 7800.0%. This contributed to the annual value of 1.13% for FY2024, which is 5500.0% up from last year.
  • Per TriSalus Life Sciences' latest filing, its Return on Equity stood at 1.72% for Q3 2025, which was down 7800.0% from 1.16% recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Return on Equity registered a high of 6.38% during Q4 2023, and its lowest value of 0.2% during Q1 2023.
  • Moreover, its 4-year median value for Return on Equity was 1.23% (2024), whereas its average is 1.59%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 61100bps in 2023, then crashed by -50900bps in 2024.
  • TriSalus Life Sciences' Return on Equity (Quarter) stood at 0.27% in 2022, then skyrocketed by 2262bps to 6.38% in 2023, then plummeted by -80bps to 1.3% in 2024, then skyrocketed by 32bps to 1.72% in 2025.
  • Its Return on Equity was 1.72% in Q3 2025, compared to 1.16% in Q2 2025 and 0.9% in Q1 2025.